文献
J-GLOBAL ID:201802223617455039
整理番号:18A1472794
抗シグナル認識粒子抗体に関連した免疫仲介壊死性ミオパシーの症例:血管内大細胞型B細胞リンパ腫に対するリツキシマブ,シクロホスファミド,ドキソルビシン,ビンクリスチンおよびプレドニゾロン療法後の劇的な改善
Case of immune-mediated necrotizing myopathy associated with anti-signal recognition particle antibodies: Dramatic improvement after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone therapy for intravascular large B-cell lymphoma
著者 (10件):
Komiya Hiroyasu
(Department ofNeurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan)
,
Hagihara Maki
(Department ofHematology and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan)
,
Tanaka Kenichi
(Department ofNeurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan)
,
Tada Mikiko
(Department ofNeurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan)
,
Joki Hideto
(Department ofNeurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan)
,
Koyano Shigeru
(Department ofNeurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan)
,
Doi Hiroshi
(Department ofNeurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan)
,
Nishino Ichizo
(Department of Neuromuscular Research, National Institute of Neuroscience, Department of Genome Medicine Development, Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan)
,
Takeuchi Hideyuki
(Department ofNeurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan)
,
Tanaka Fumiaki
(Department ofNeurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan)
資料名:
Clinical and Experimental Neuroimmunology (Web)
(Clinical and Experimental Neuroimmunology (Web))
巻:
9
号:
3
ページ:
177-181
発行年:
2018年
JST資料番号:
U0510A
ISSN:
1759-1961
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)